Paper
combined organic layers were dried (Na2SO4), concentrated in
vacuo, and the residue was purified by chromatography (flash
silica gel, heptane–EtOAc) to give 6 and/or 7, 10 and/or 11.
References
1 According to the IUPAC nomenclature, a benzo-η-carboline
(here) is a 10H-indolo[3,2-b]quinoline.
2 D. Dwuma-Badu, J. S. K. Ayin, N. I. Y. Fiagbe, J. E. Knapp,
P. L. Shiff and D. J. J. Slatkin, Pharm. Sci., 1978, 67, 433.
3 E. Clinquart, Bull. Acad. R. Med. Belg., 1929, 9, 627.
4 A. N. Tackie, M. H. M. Sharaf, P. L. Schiff, Jr., G. L. Boye,
R. C. Crouch and G. E. Martin, J. Heterocycl. Chem., 1991,
28, 1429.
5 H. W. Rauwald, M. Kober, E. Mutschler and G. Lambrecht,
Planta Med., 1992, 58, 486.
6 K. Cimanga, T. de Bruyne, A. Lasure, B. van Poel, L. Pieters,
M. Claeys, D. Vanden Berghe, K. Kambu, L. Tona and
A. J. Vlietinck, Planta Med., 1996, 62, 22.
7 K. Cimanga, T. de Bruyne, L. Pieters, A. J. Vlietinck and
C. A. Turger, J. Nat. Prod., 1997, 60, 688.
8 C. L. Yang, C. H. Tseng, Y. L. Chen, C. M. Lu, C. L. Kao,
M. H. Wu and C. C. Tzeng, Eur. J. Med. Chem., 2010, 45,
602.
9 Y. L. Chen, C. H. Chung, I.-L. Chen, P. H. Chen and
H. Y. Jeng, Bioorg. Med. Chem., 2002, 10, 2705.
10 D. Edmont, R. Rocher, C. Plisson and J. Chenault, Bioorg.
Med. Chem. Lett., 2000, 10, 1831.
11 D. Narsinh and S. Anamik, Indian J. Pharm. Sci., 2001, 63,
211.
11-Benzyl-2-methylbenzofuro[3,2-b]quinoline (6a)
Following general procedure A, 6a was prepared from 3-bromo-
2-(phenylethynyl)benzofuran (4a) (150 mg, 0.5 mmol),
Pd(OAC)2 (11 mg, 10 mol%), P(t-Bu)3·HBF4 (29 mg, 20 mol%),
4-methylaniline (5a) (70 mg, 0.65 mmol), toluene (5 mL), KO-t-
Bu (112 mg, 1.0 mmol), as a brown solid (98 mg, 60%); mp
1
170–172 °C. H NMR (300 MHz, CDCl3): δ = 2.45 (s, 3H, CH3),
4.66 (s, 2H, CH2), 7.06–7.22 (m, 5H, ArH), 7.34–7.39 (m, 1H,
ArH), 7.44 (dd, 1H, J = 1.8, 8.8 Hz, ArH), 7.51–7.54 (m, 2H,
ArH), 7.78 (brs, 1H, ArH), 8.12 (d, 1H, J = 8.8 Hz, ArH),), 8.30
(d, 1H, J = 7.7 Hz, ArH). 13C NMR (62.9 MHz, CDCl3): δ = 22.1
(CH3), 31.1 (CH2), 122.2, 122.9, 123.5 (CH), 125.1 (C), 126.4
(CH), 126.6 (C), 128.4, 128.6, 129.5, 130.0, 130.5 (CH), 136.0,
138.6, 145.0, 145.7, 147.0, 159.2 (C). IR (KBr): ν = 3056, 3023,
2946, 2914, 2857, 2731, 1621 (w), 1594 (m), 1575, 1565, 1551
(w), 1502, 1491 (m), 1469 (w), 1443 (m), 1426, 1402, 1376,
1364, (w), 1337 (m), 1286, 1262, 1231 (w), 1184 (s), 1179, 1169,
1146, 1123, (w), 1109, 1068, 1043 (m), 1024, 1015, 1001, 958,
927, 903, 872, 858 (w), 820 (s), 783, 763 (m), 748, 732, 702 (s),
691, 672 (w), 644 (m), 620 (w), 589, 571, 554, cm−1. GC-MS (EI,
70 eV): m/z (%) = 323 ([M]+, 100), 322 (22), 308 (13), 307 (13),
246 (13). HRMS (EI, 70 eV): calcd for C23H17NO [M]+:
323.13047; found: 323.130011.
12 A. Shi, T. A. Nguyen, S. K. Battina, S. Rana, D. J. Takemoto,
P. K. Chiang and D. H. Hua, Bioorg. Med. Chem. Lett., 2008,
18, 3364.
13 H. Mahesh, C. Reddy, K. V. Reddy, P. V. K. S. Raju and
V. V. Reddy, Synth. Commun., 2004, 34, 4089.
14 A. A. Avetisyan, I. L. Aleksanyan and A. A. Pivazyan,
Russ. J. Org. Chem., 2006, 42, 739.
2-Ethyl-11-(4-methoxybenzyl)benzofuro[3,2-b]quinoline (6q)
Following general procedure A, 6q was prepared from 3-bromo-
2-((4-methoxyphenyl)ethynyl)benzofuran
0.5 mmol), Pd(OAC)2 (11 mg, 10 mol%), P(t-Bu)3·HBF4 (29 mg,
20 mol%), 4-ethylaniline (5d) (78 mg, 0.65 mmol), toluene 16 Y. Kawase, S. Yamaguchi, O. Maeda, A. Hayashi, K. Tabata
(5 mL), KO-t-Bu (112 mg, 1.0 mmol), as a brown solid (120 mg, and M. Kondo, J. Heterocycl. Chem., 1979, 16, 487.
72%); mp 160–162 °C. H NMR (250 MHz, CDCl3): δ = 1.23 (t, 17 Y. Kawase, S. Yamaguchi, M. Morita and T. Uesugi, Bull.
3H, J = 7.6 Hz, CH3), 2.76 (q, 2H, J = 7.6 Hz, CH2), 3.63 (s, 3H, Chem. Soc. Jpn., 1980, 53, 1057.
OCH3), 4.60 (s, 2H, CH2), 6.70 (d, 2H, J = 8.7 Hz, ArH), 7.13 (d, 18 L. W. Deady, A. J. Kaye, G. J. Finlay, B. C. Baguley and
2H, J = 8.7 Hz, ArH), 7.33–7.39 (m, 1H, ArH), 7.47 (dd, 1H, J = W. A. Denny, J. Med. Chem., 1997, 40, 2040.
(4c)
(150
mg, 15 A. A. Avetisyan, I. L. Aleksanyan and K. S. Sargsyan,
Russ. J. Org. Chem., 2007, 43, 426.
1
1.8, 8.7 Hz, ArH), 7.51–7.54 (m, 2H, ArH), 7.82 (brs, 1H, ArH), 19 X. Y. Zhu, L. G. Mardenborough, S. Li, A. Khan, W. Zhang,
8.14 (d, 1H, J = 8.7 Hz, ArH), 8.30 (d, 1H, J = 7.8 Hz, ArH). 13C
NMR (62.9 MHz, CDCl3): δ = 15.4 (CH3), 29.2, 30.3 (2CH2), 55.2
P. Fan, M. Jacob, L. Walker and S. Y. Ablordeppey, Bioorg.
Med. Chem., 2007, 15, 686, and references cited therein.
(OCH3), 112.2, 114.1, 121.7, 122.2, 123.4 (CH), 123.5, 125.7, 20 (a) M. S. Butler, J. Nat. Prod., 2004, 67, 2141; (b) J. A. Joule
126.6 (C), 128.9, 129.4, 129.7, 130.5 (CH), 130.7, 142.0, 145.3,
and K. Mills, Heterocyclic Chemistry, Blackwell Science,
145.8, 146.9, 158.2, 159.2 (C). IR (KBr): ν = 3055, 3024, 2956,
Oxford, 2000.
2923, 2866, 1621 (w), 1607 (m), 1575, 1564, 1555 (w), 1507 (s), 21 For general reviews on the metal-catalyzed synthesis of het-
1470 (w), 1445 (m), 1403, 1366 (w), 1340, 1331 (m), 1285, 1264
(w), 1245 (s), 1230, 1179, 1170, 1148, 1128 (w), 1110 (m), 1068,
1056 (w), 1042 (m), 1025, 1015, 1001, 993, 981, 953, 937, 927,
908, 899 (w), 878 (m), 856 (w), 830 (s), 784, 760, 748 (m), 733,
725, 700 (s), 672, 646, 620, 605, 587, 556 (m), cm−1. GC-MS (EI,
70 eV): m/z (%) = 367 ([M]+, 100), 352 (15), 338 (17), 322 (06),
erocycles, see: (a) I. Nakamura and Y. Yamamoto, Chem.
Rev., 2004, 104, 2127; (b) T. L. Gilchrist, J. Chem. Soc.,
Perkin Trans. 1, 1999, 2849; (c) J. F. Hartwig, Synlett, 2006,
1283; (d) L. Jiang and S. L. Buchwald, in Metal-Catalyzed
Cross-Coupling Reactions, ed. A. de Meijere and F. Dieder-
ich, Wiley-VCH, Weinheim, 2nd edn, 2004, p. 699.
307 (10), 294 (08), 259 (06). HRMS (EI, 70 eV): calcd for 22 (a) L. Ackermann, S. Barfüßer and H. K. Potukuchia, Adv.
C25H21NO2 [M]+: 367.15668; found: 367.156544.
Synth. Catal., 2009, 351, 1064; (b) L. Ackermann,
9472 | Org. Biomol. Chem., 2012, 10, 9464–9473
This journal is © The Royal Society of Chemistry 2012